Launch of Copaxone 20 mg can add Rs 8-10 to FY19 EPS for Natco: HDFC Securities News News / News 7 years ago 599 Views comments Natco Pharma rallies in trade as Mylan gets US Food and Drug Administration (US FDA) nod for Copaxone. In an interview to CNBC-TV18, Amey Chalke, Rese... Read more
News Why MM#39;s acquisition of Turkish tractor firms sits well with its overall strategy News / News - 7 years ago
Comments